Fredrik Wermeling Selected Research

Tenascin

12/2021

Biased TCR gene usage in citrullinated Tenascin C specific T-cells in rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fredrik Wermeling Research Topics

Disease

9	Inflammation (Inflammations) 12/2022 - 12/2008
9	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 10/2007
6	Neoplasms (Cancer) 07/2023 - 04/2012
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 10/2007
3	Arthritis (Polyarthritis) 11/2023 - 06/2011
3	Rheumatoid Arthritis 12/2022 - 01/2018
2	Disease Progression 11/2023 - 10/2007
2	Neuroblastoma 07/2023 - 01/2016
2	Atherosclerosis 01/2019 - 06/2011
2	Infections 01/2016 - 04/2012
1	Hypoxia (Hypoxemia) 01/2023
1	Melanoma (Melanoma, Malignant) 01/2022
1	Human Influenza (Influenza) 01/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2021
1	Leukemia 01/2020
1	Hyperplasia 01/2019
1	Pain (Aches) 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Aneurysm (Aneurysms) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2016
1	Colitis 04/2016
1	Lymphoma (Lymphomas) 01/2016
1	Cystic Fibrosis (Mucoviscidosis) 01/2014
1	Pneumonia (Pneumonitis) 01/2014
1	Chronic Mucocutaneous Candidiasis 05/2013
1	type 1 Autoimmune polyendocrinopathy syndrome 05/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2011

Drug/Important Bio-Agent (IBA)

8	AutoantibodiesIBA 12/2022 - 10/2007
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2016
4	AntibodiesIBA 01/2023 - 04/2012
4	AutoantigensIBA 01/2018 - 10/2007
3	Interleukin-4 (Interleukin 4)IBA 11/2020 - 06/2011
3	Immunoglobulin G (IgG)IBA 01/2019 - 04/2012
3	CytokinesIBA 01/2014 - 06/2011
3	Intravenous Immunoglobulins (IVIG)FDA Link 08/2013 - 12/2008
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2023 - 12/2021
2	AntigensIBA 12/2021 - 01/2019
2	Interleukin-2 (IL2)IBA 01/2021 - 01/2016
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2019 - 04/2012
2	LigandsIBA 08/2013 - 06/2011
2	Scavenger Receptors (Scavenger Receptor)IBA 06/2011 - 10/2007
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 11/2023
1	Drug CombinationsIBA 07/2023
1	nutlin 3IBA 01/2023
1	Malondialdehyde (Propanedial)IBA 12/2022
1	Sulfhydryl Compounds (Thiols)IBA 12/2022
1	Cysteine (L-Cysteine)FDA Link 12/2022
1	LipidsIBA 12/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	Tumor Suppressor Protein p53IBA 01/2022
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2022
1	serum P-component (CIt)IBA 12/2021
1	TenascinIBA 12/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 11/2020
1	Interleukin-13IBA 11/2020
1	Serum Response FactorIBA 01/2020
1	Collagen Type II (Type II Collagen)IBA 01/2019
1	Fc Receptors (Fc Receptor)IBA 01/2019
1	Pancreatic Elastase (Elastase)IBA 01/2019
1	Cartilage Oligomeric Matrix ProteinIBA 01/2019
1	Anti-Citrullinated Protein AntibodiesIBA 01/2018
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2018
1	A-factor (Streptomyces)IBA 04/2016
1	Wiskott-Aldrich Syndrome ProteinIBA 01/2016
1	CeramidesIBA 01/2014
1	ProfilIBA 01/2014
1	STAT6 Transcription FactorIBA 08/2013
1	CystatinsIBA 05/2013
1	Polysaccharides (Glycans)IBA 04/2012
1	Interleukin-33IBA 06/2011
1	oxidized low density lipoproteinIBA 06/2011
1	Biomarkers (Surrogate Marker)IBA 07/2010

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2019
1	Drug Therapy (Chemotherapy) 01/2023
1	Radiotherapy 01/2022